| abstract |
anti-c5a antibodies and methods for using the antibodies. the present invention relates, inter alia, to antibodies or antigen binding fragments thereof, which bind c5a, and to the use of antibodies in methods to treat or prevent disorders associated with complement, such as, but without limitation, hemolytic uremic syndrome atypical, age-related macular degeneration, rheumatoid arthritis, sepsis, severe burn, antiphospholipid syndrome, asthma, lupus nephritis, goodpasture syndrome, and chronic obstructive pulmonary disease. |